Dr. Charlotte Dai Kubicky, MD, PhD

Dr. Kubicky practices at Sutter Imaging Roseville II in Roseville, California.

Dr. Kubicky's NPI, 1194935858, was assigned on May 23, 2007. Dr. Kubicky graduated from Perelman School of Medicine - Philadelphia in 2002. Dr. Kubicky's California license number on file is A85664.

Dr. Kubicky's primary practice is Sutter Imaging Roseville II, at 2 Medical Plaza Ste 105, Roseville, CA 95661. The practice phone is (916) 865-1469.

Dr. Kubicky's primary practice is Sutter Imaging Roseville II in Roseville, California. Dr. Kubicky is also affiliated with Sutter Roseville Medical Center. The medical group on file is SGMF Radiology. Dmand AI also links Dr. Kubicky to 1 more hospital, 1 group practice or clinic and 1 medical group, each named with a free account. Dr. Kubicky's employer is on file too: a breast imaging center.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kubicky practices, 4 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Kubicky's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Kubicky is board certified in radiation oncology by the American Board of Radiology. Dmand AI has Dr. Kubicky's licenses on file in 3 states: California, Washington and Oregon.

Dmand AI lists bone cancer radiation, brain cancer radiation, brain tumor radiation, breast cancer radiation, lung cancer radiation and lymphoma radiation among the conditions Dr. Kubicky treats.

CMS data shows 4,397 Medicare services from Dr. Kubicky across 25 procedure codes in 2024, for 294 Medicare patients. Medicare paid $796,692 for them.

CMS counts 294 Medicare patients who saw Dr. Kubicky in 2024. The largest group is 75 to 84, with 126 patients. 75% of them have cancer, and 75% have high blood pressure. 13% are also on Medicaid. Their average risk score is 1.45, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Kubicky's median patient age at 72, with 66% women.

In 2024, Dr. Kubicky wrote 56 Medicare Part D claims for 40 patients. 70% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $76 in total drug cost. In 2023, CMS named 22 claims across 2 drugs.

Dr. Kubicky accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kubicky as offering telehealth.

Dmand AI links 24 papers to Dr. Kubicky, published from 2008 to 2023. 2015 was the busiest year, with 5. The most frequent topics are Breast Neoplasms, Mastectomy, Segmental and Breast. Dr. Kubicky has published most often in Ann Surg Oncol. Dr. Kubicky's most frequent co-authors are Laurie W. Cuttino, MD, Judy C. Boughey, MD and Bruce G. Haffty, MD.

CMS Open Payments shows 17 general payments to Dr. Kubicky from 9 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 79% of the total. Janssen Pharmaceuticals, Inc paid the most, $452.

Dr. Kubicky graduated from Perelman School of Medicine - Philadelphia in 2002.

Dr. Kubicky is in network with 15 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.